Taking aim at IDH in fitter patients with AML

Blood. 2021 Apr 1;137(13):1706-1707. doi: 10.1182/blood.2020009361.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Isocitrate Dehydrogenase* / genetics
  • Leukemia, Myeloid, Acute* / genetics

Substances

  • Isocitrate Dehydrogenase